Study of Screening Brain MRIs in Stage IV Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Asian Multicenter Prospective Study of ctDNA Sequencing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE1
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
- Status
- RECRUITING
- Phase
- PHASE3
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
- Status
- COMPLETED
- Phase
- PHASE1
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study
- Status
- UNKNOWN
- Phase
- PHASE2